<DOC>
	<DOCNO>NCT02094729</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics , immunogenicity , pharmacodynamic response repeat intravenous infusion BAN2401 subject mild cognitive impairment ( MCI ) due Alzheimer 's disease ( AD ) mild Alzheimer 's disease .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled Study Assess Safety , Tolerability , Pharmacokinetics , Immunogenicity , Pharmacodynamic Response Repeated Intravenous Infusions BAN2401 Subjects With Mild Cognitive Impairment Due Alzheimer 's Disease Mild Alzheimer 's Disease</brief_title>
	<detailed_description>This multicenter , randomize , placebo-controlled , double-blind , multiple ascend dose study total 24 subject ( 8 subject per cohort ) MCI due AD mild AD . The study consist three cohort evaluate safety , tolerability PK BAN2401 three dose level ( 2.5 , 5 , 10 mg/kg ) . Each cohort consist Screening Period randomization , Treatment Period randomization last dose , Follow-up Period last dose . Cohorts 1 , 2 , 3 receive 2.5 mg/kg , 5 mg/kg , 10 mg/kg BAN2401 , respectively .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Inclusion Criteria MCI due AD 1 . Subjects clinical cognitive symptom consistent National Institute AgingAlzheimer 's Association ( NIAAA ) core criterion MCI 2 . Subjects Clinical Dementia Rating ( CDR ) 0.5 memory box score 0.5 great Screening 3 . Subjects report history subjective memory decline slow progression least 1 year Screening , subject whose information provider attend physician report history memory decline slow progression least 1 year Screening 4 . Subjects objective impairment episodic memory indicate 11.5 standard deviation ageadjusted mean Wechsler Memory ScaleRevised ( WMSR ) logical memory II ( delay recall ) Screening : le equal 15 age 50 64 year less equal 12 age 65 69 year less equal 11 age 70 74 year less equal 9 age 75 79 year less equal 7 age 80 90 year Mild AD 5 . Subjects meet NIAAA core clinical criterion probable AD 6 . Subjects CDR 0.5 1.0 memory box score 0.5 great Screening All subject 7 . Male female subject age 50 90 year , inclusive , obtain informed consent 8 . Subjects Mini Mental State Examination ( MMSE ) score great equal 22 less equal 30 Screening 9 . Body Mass Index ( BMI ) less 35 kg/m2 Screening 10 . Females must pregnant lactating , specify contraceptive precaution must follow 11 . Subjects must identify caregivers/informants 12 . Must informant caregiver provide write informed consent voluntarily able spend 3 day week subject ( 4 hour per day ) , able support subject study period provide necessary patient information , assist treatment compliance , accompany subject schedule visit ( need ) throughout study . 13 . Provide voluntary write informed consent ( obtain much possible subject , mandatory legal guardian ) . 14 . Willing able comply aspect protocol . Exclusion Criteria 1 . Any neurological condition may affect cognitive impairment 2 . History transient ischemic attack ( TIA ) , stroke , seizure within 12 month Screening 3 . Any psychiatric diagnosis symptom ( e.g. , hallucination , major depression , delusion ) could interfere study procedure subject 4 . Any medical device contraindicate MRI scan ( e.g. , cardiac pacemaker/defibrillator , ferromagnetic metal implant , device approve safe use MRI scanner ) 5 . Evidence infection , tumor , stroke clinically significant lesion could indicate dementia diagnosis AD brain MRI Screening 6 . Evidence clinically significant lesion could indicate dementia diagnosis AD brain MRI Screening , significant pathological finding brain MRI Screening 7 . A prolonged QT interval ( QTcF great equal 450 m ) demonstrate repeat ECG Screening 8 . Any clinically significant condition ( e.g. , cardiac , respiratory , gastrointestinal , renal disease ) opinion investigator ( ) could affect subject 's safety interfere study assessment 9 . Severe visual hearing impairment would prevent subject perform psychometric test accurately .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>mild cognitive impairment</keyword>
	<keyword>Alzheimer 's disease</keyword>
</DOC>